Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀüÀ̼º ¹æ±¤¾Ï ȯÀÚÀÇ M-VAC (Methotrexate, Vinblastin, Adriamycin, Cisplatin) º´¿ë ¿ä¹ý M-VAC Combination Chemotherapy in Advanced Bladder Cancer

´ëÇѺñ´¢±â°úÇÐȸÁö 1987³â 28±Ç 1È£ p.74 ~ 78
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ°æ¼·/Lee KS ±èõÀÏ/À̼ºÁØ/Kim CI/Lee SC

Abstract


Patients with advanced carcinoma of the bladder that relapses or persists after conventional therapy have a poor prognosis. The management of the patient with
recurrent local or disseminated bladder cancer presents a difficult clinical problem. In l985, Sternberg et al reported 7l% significant tumor regression and 50% complete clinical remission with M-VAC(Methotrexate, Vinblastin, Adriamycin and Cisplatin) combination chemotherapy for treatment of advanced bladder carcinoma Herein, we report 4 cases of M-VAC combination chemotherapy in far advanced bladder carcinoma with had measurable metastatic lesions enough to evaluate the objective response of chemotherapy.

Å°¿öµå

¹æ±¤Á¾¾ç; È­Çпä¹ý; bladder cancer; chemotherapy; M-VAC

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS